The association says it is 'astonished' after the federal government disregarded the findings of a Senate inquiry, failed to consult, and used the last day of the parliamentary sitting year to table enabling legislation that will cut the value of the R&D Tax Incentive.
AusBiotech 'astonished' after R&D tax cut legislation tabled on final day
December 6, 2019 Latest NewsLatest Video
New Stories
-
Gilead announces eight recipients of inaugural Community Grants Program
March 28, 2024 - - Latest News -
Groups call for a new approach to reviewing and funding cancer medicines
March 28, 2024 - - Latest News -
Auditor General extends time to contribute to PBS performance audit
March 28, 2024 - - Latest News -
Reform bill redefines political donation and could exclude the industry from participating
March 27, 2024 - - Latest News -
NZ Government delivers funding boost for patients travelling to health treatment
March 27, 2024 - - Latest News -
Clarity Pharmaceuticals launches $121 million fully underwritten equity raising
March 26, 2024 - - Australian Biotech -
More states announce RSV programs as families call for national action
March 26, 2024 - - Latest News